CAS RN: 142273-20-9 | Product Number: K0052
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
|Purity / Analysis Method||>97.0%(HPLC)|
|Molecular Formula / Molecular Weight||C__1__6H__1__1BrN__2O = 327.18|
|Physical State (20 deg.C)||Solid|
|Store Under Inert Gas||Store under inert gas|
|Condition to Avoid||Air Sensitive,Heat Sensitive|
|Reaxys Registry Number||5346108|
|PubChem Substance ID||253661159|
|Appearance||White to Almost white powder to crystal|
|Purity(HPLC)||min. 97.0 area%|
|Elemental analysis(Nitrogen)||8.00 to 9.00 %|
|Hazard Statements||H315 : Causes skin irritation.
H319 : Causes serious eye irritation.
|Precautionary Statements||P264 : Wash skin thoroughly after handling.
P280 : Wear protective gloves/ eye protection/ face protection.
P302 + P352 : IF ON SKIN: Wash with plenty of water.
P337 + P313 : If eye irritation persists: Get medical advice/ attention.
P362 + P364 : Take off contaminated clothing and wash it before reuse.
P332 + P313 : If skin irritation occurs: Get medical advice/ attention.
- The specificities of protein kinase inhibitors: an update
- The selectivity of protein kinase inhibitors: a further update
- Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
- Small molecule GSK-3 inhibitors increase neurogenesis of human neural progenitor cells
- Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4
Safety Data Sheet (SDS) Search
The requested SDS is not available.
Please check that the Product Number you have entered is correct.
If your information is correct and you are still not able to view the requested SDS, please Contact Us for more information.